Cargando…

Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis

Reliable vascular access is necessary for effective hemodialysis. Guidelines recommend chronic hemodialysis via an arteriovenous fistula (AVF), however, in a significant number of patients, permanent central venous catheters (CVCs) are used. The use of a tunneled catheter is acceptable if the estima...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymańska, Joanna, Kakareko, Katarzyna, Rydzewska-Rosołowska, Alicja, Głowińska, Irena, Hryszko, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196553/
https://www.ncbi.nlm.nih.gov/pubmed/34063913
http://dx.doi.org/10.3390/jcm10112230
_version_ 1783706712433229824
author Szymańska, Joanna
Kakareko, Katarzyna
Rydzewska-Rosołowska, Alicja
Głowińska, Irena
Hryszko, Tomasz
author_facet Szymańska, Joanna
Kakareko, Katarzyna
Rydzewska-Rosołowska, Alicja
Głowińska, Irena
Hryszko, Tomasz
author_sort Szymańska, Joanna
collection PubMed
description Reliable vascular access is necessary for effective hemodialysis. Guidelines recommend chronic hemodialysis via an arteriovenous fistula (AVF), however, in a significant number of patients, permanent central venous catheters (CVCs) are used. The use of a tunneled catheter is acceptable if the estimated dialysis time is less than a year or it is not possible to create an AVF. The main complications associated with CVC include thrombosis and catheter-related bloodstream infections (CRBSIs), which may result in loss of vascular access. The common practice is to use locking solutions to maintain catheter patency and minimize the risk of CRBSI. This paperwork summarizes information on currently available locking solutions for dialysis catheters along with their effectiveness in preventing thrombotic and infectious complications and describes methods of dealing with catheter dysfunction. The PubMed database was systematically searched for articles about locking solutions used in permanent CVCs in hemodialysis patients. Additional studies were identified by searching bibliographies and international guidelines. Articles on end-stage kidney disease patients dialyzed through a permanent CVC were included. Information from each primary study was extracted using pre-determined criteria including thrombotic and infectious complications of CVC use, focusing on permanent CVC if sufficient data were available. Of the currently available substances, it seems that citrate at a concentration of 4% has the best cost-effectiveness and safety profile, which is reflected in the international guidelines. Recent studies suggest the advantage of 2+1 protocols, i.e., taurolidine-based solutions with addition of urokinase once a week, although it needs to be confirmed by further research. Regardless of the type of locking solution, if prophylaxis with a thrombolytic agent is chosen, it should be started from the very beginning to reduce the risk of thrombotic complications. In case of CVC dysfunction, irrespective of the thrombolysis attempt, catheter replacement should be planned as soon as possible.
format Online
Article
Text
id pubmed-8196553
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81965532021-06-13 Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis Szymańska, Joanna Kakareko, Katarzyna Rydzewska-Rosołowska, Alicja Głowińska, Irena Hryszko, Tomasz J Clin Med Review Reliable vascular access is necessary for effective hemodialysis. Guidelines recommend chronic hemodialysis via an arteriovenous fistula (AVF), however, in a significant number of patients, permanent central venous catheters (CVCs) are used. The use of a tunneled catheter is acceptable if the estimated dialysis time is less than a year or it is not possible to create an AVF. The main complications associated with CVC include thrombosis and catheter-related bloodstream infections (CRBSIs), which may result in loss of vascular access. The common practice is to use locking solutions to maintain catheter patency and minimize the risk of CRBSI. This paperwork summarizes information on currently available locking solutions for dialysis catheters along with their effectiveness in preventing thrombotic and infectious complications and describes methods of dealing with catheter dysfunction. The PubMed database was systematically searched for articles about locking solutions used in permanent CVCs in hemodialysis patients. Additional studies were identified by searching bibliographies and international guidelines. Articles on end-stage kidney disease patients dialyzed through a permanent CVC were included. Information from each primary study was extracted using pre-determined criteria including thrombotic and infectious complications of CVC use, focusing on permanent CVC if sufficient data were available. Of the currently available substances, it seems that citrate at a concentration of 4% has the best cost-effectiveness and safety profile, which is reflected in the international guidelines. Recent studies suggest the advantage of 2+1 protocols, i.e., taurolidine-based solutions with addition of urokinase once a week, although it needs to be confirmed by further research. Regardless of the type of locking solution, if prophylaxis with a thrombolytic agent is chosen, it should be started from the very beginning to reduce the risk of thrombotic complications. In case of CVC dysfunction, irrespective of the thrombolysis attempt, catheter replacement should be planned as soon as possible. MDPI 2021-05-21 /pmc/articles/PMC8196553/ /pubmed/34063913 http://dx.doi.org/10.3390/jcm10112230 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szymańska, Joanna
Kakareko, Katarzyna
Rydzewska-Rosołowska, Alicja
Głowińska, Irena
Hryszko, Tomasz
Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
title Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
title_full Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
title_fullStr Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
title_full_unstemmed Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
title_short Locked Away—Prophylaxis and Management of Catheter Related Thrombosis in Hemodialysis
title_sort locked away—prophylaxis and management of catheter related thrombosis in hemodialysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196553/
https://www.ncbi.nlm.nih.gov/pubmed/34063913
http://dx.doi.org/10.3390/jcm10112230
work_keys_str_mv AT szymanskajoanna lockedawayprophylaxisandmanagementofcatheterrelatedthrombosisinhemodialysis
AT kakarekokatarzyna lockedawayprophylaxisandmanagementofcatheterrelatedthrombosisinhemodialysis
AT rydzewskarosołowskaalicja lockedawayprophylaxisandmanagementofcatheterrelatedthrombosisinhemodialysis
AT głowinskairena lockedawayprophylaxisandmanagementofcatheterrelatedthrombosisinhemodialysis
AT hryszkotomasz lockedawayprophylaxisandmanagementofcatheterrelatedthrombosisinhemodialysis